HSV-1 ICP4 Immediate Early Protein (HSV-1 ICP4) Antikörper

Antigen: HSV-1 ICP4 Immediate Early Protein (HSV-1 ICP4)

Klonalität: Monoklonal (10F1)

Wirt: Maus

Applikation: Western Blot (WB), Immunfluoreszenz (IF), ELISA

Produktnummer: ABIN265556

Produktbeschreibung

Format: Affinity-purified

Isotyp: IgG1-kappa  (Passende Sekundärantikörper)

Klon: 10F1

Beschreibung: Synonyms: ICP4, IE175

Anwendungen

Applikationshinweise: Western Blotting: > 1:600. Immunofluorescence: 1+ at 1:25.600. ELISA: 0.100 at 1:26.600

Konzentration: 1.0 mg/ml

Reinheit: Affinity Purified, > 95% IgG by SDS-PAGE

Buffer: Phosphate Buffered Saline pH 7.4 (no azide)

Forschungsgebiet: Virologie

Beschränkungen: Nur für Forschungszwecke einsetzbar

Bilder

Immunofluorescence

Western Blotting

Publikationen

Publikationen: Mullen, Gerstberger, Ciufo et al.: "Evaluation of colocalization interactions between the IE110, IE175, and IE63 transactivator proteins of herpes simplex virus within subcellular punctate structures." in: Journal of virology, Vol. 69, Issue 1, pp. 476-91, 1995 (PubMed).

Satoh, Arii, Suenaga et al.: "PILRalpha is a herpes simplex virus-1 entry coreceptor that associates with glycoprotein B." in: Cell, Vol. 132, Issue 6, pp. 935-44, 2008 (PubMed).

Shen, Sa e Silva, Jaber et al.: "Two small RNAs encoded within the first 1.5 kilobases of the herpes simplex virus type 1 latency-associated transcript can inhibit productive infection and cooperate to inhibit apoptosis." in: Journal of virology, Vol. 83, Issue 18, pp. 9131-9, 2009 (PubMed).

Bolstad, Abaitua, Crump et al.: "Autocatalytic activity of the ubiquitin-specific protease domain of herpes simplex virus 1 VP1-2." in: Journal of virology, Vol. 85, Issue 17, pp. 8738-51, 2011 (PubMed). (1:1000). Weitere Details: Target proteins were visualized by enhanced chemiluminescence (ECL, Pierce).